# BullFrog AI (BFRG) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/BFRG
## Company Profile
- Ticker: BFRG
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.5032 USD
- Market cap: 14277071.27 USD
- Last updated: 2026-09-04
## Business Overview
BullFrog AI is an AI-enabled healthcare company focused on applying machine learning to drug discovery and biological data. Its business sits at the intersection of analytics and biotech research.
## Why The Stock Is Moving

As of Sep 4, 2026, BFRG closed up 2.69% at $0.5032. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, BullFrog sits in AI-enabled biotech infrastructure.

## Business Model

The company depends on platform adoption, data partnerships, and the translation of AI tools into research value.

## Landscape Position

BullFrog is a hybrid AI-biotech infrastructure name rather than a direct drug developer.

## Future Catalysts

- BullFrog AI’s catalysts are AI-platform partnerships and any proof that the analytics business can turn into recurring revenue. The market will want to see whether the platform can gain more practical use in biotech.

## Recent News
- 2026-07-22 20:15 EST — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e) — Source: BullFrog AI
- 2026-07-21 20:15 EST — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8) — Source: BullFrog AI
- 2026-06-02 12:00 EST — [BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform](https://biopharmsignal.com/news/BFRG/bullfrog-ai-announces-new-commercial-leadership-team-to-execute-growth-strategy-for-its-integrated-pharma-ai-platform) — Source: BullFrog AI
- 2026-04-22 11:30 EST — [BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement](https://biopharmsignal.com/news/BFRG/bullfrog-ai-regains-compliance-with-nasdaq-shareholders-equity-requirement) — Source: BullFrog AI
- 2026-04-14 11:30 EST — [BullFrog AI Announces Participation at AACR Annual Meeting](https://biopharmsignal.com/news/BFRG/bullfrog-ai-announces-participation-at-aacr-annual-meeting) — Source: BullFrog AI